NEXT

The Legal Intelligencer

EDPA Becomes Hub for Generic Drug Antitrust Litigation

A multidistrict antitrust litigation over the generic drugs Digoxin and Doxycycline has been significantly expanded to include numerous additional class action cases, all stemming from a wide-ranging federal probe that last year led two pharmaceutical executives to plead guilty to price-fixing charges.
7 minute read

The Legal Intelligencer

Xarelto Makers Want Plaintiffs' Litigation Funding Info

Defendant drug companies in the Xarelto mass tort want to know how the plaintiffs are funding their lawsuits.
3 minute read

New York Law Journal

Feds Accuse Shkreli, Ex-Counsel of 'Ramping Up' Row as Trial Strategy

A federal prosecutor in the securities fraud case against pharmaceutical executive Martin Shkreli and his ex-counsel Evan Greebel accused the defendants on Friday of strategically “ramping up” the animosity between them in an effort to sever their cases.
4 minute read

New York Law Journal

Shkreli and Ex-Counsel Seek Separate Trial Paths

As the fraud case against former pharmaceutical executive Martin Shkreli moves closer to trial, attorneys for the controversial "Pharma Bro" and for co-defendant Evan Greebel, Shkreli's former counsel, will argue Friday in the Eastern District of New York that they should be tried separately.
4 minute read

National Law Journal

Fresh Test of 'Patent Dance' Lands at Federal Circuit

Weighing a case pitting Amgen against Hospira, the appeals court panel sounded unsure how much specificity is required by the Biologics Price Competition and Innovation Act.
4 minute read

Legal Week

Simpson Thacher and Davis Polk bag lead roles on AstraZeneca's $2.7bn US pharma acquisition

UK pharmaceutical giant turns to US firm as it buys kidney disease treatment maker ZS Pharma amid booming M&A market
14 minute read

International Edition

Slaughters and Sullivan & Cromwell among firms advising as Shire buys Dyax for $5.9bn

Firms win roles in latest pharma deal as UK-listed Shire moves to buy US biotech group Dyax
1 minute read

Legal Week

Slaughters and Sullivan & Cromwell among firms advising as Shire buys Dyax for $5.9bn

Firms win roles in latest pharma deal as UK-listed Shire moves to buy US biotech group Dyax
2 minute read

International Edition

Latham and Simpson Thacher advise on $8bn science real estate buyout

US duo take lead roles as Blackstone Group agrees to buy medical real estate company BioMed Realty Trust
2 minute read

Legal Week

Latham and Simpson Thacher advise on $8bn science real estate buyout

US duo take lead roles as Blackstone Group agrees to buy medical real estate company BioMed Realty Trust
19 minute read

Resources

  • White Collar Investigation Practice: Global Expertise in Complex Investigations

    Brought to you by HaystackID

    Download Now

  • Criminal Division's Evaluation of Corporate Compliance Programs: September 2024 Updates Review

    Brought to you by NAVEX Global

    Download Now

  • Data Management and Analytics: The Key to Success for Legal Operations

    Brought to you by DiliTrust

    Download Now

  • Small Law Firm Playbook: The Expert's Guide to Getting the Most Out of Legal Software

    Brought to you by PracticePanther

    Download Now